Kovina Therapeutics

Antiva Biosciences

This company develops topical antiviral treatments for high-risk human papillomavirus infections and pre-cancerous cervical lesions in women.

Ayuvant

The company develops RNA nanoparticle immunotherapies to treat cancer patients who do not respond to existing immune checkpoint inhibitors.

Halo Therapeutics

This company develops small-molecule antiviral nasal sprays to treat respiratory viral infections for patients suffering from conditions like Covid-19.

Agenovir

This company develops nuclease-based anti-viral therapeutics to eliminate pathogenic viral genomes for healthcare providers treating patients with persistent viral infections.

ReViral

This company develops antiviral therapeutics for respiratory syncytial virus to treat pediatric, immunocompromised and elderly patients.

Antios Therapeutics

This clinical-stage biopharmaceutical company develops antiviral therapies to treat and cure patients with chronic hepatitis B virus infections.

THERAtRAME

The company develops small molecule inhibitors targeting tRNA epitranscriptomics to treat resistant and immune-refractory cancers for patients with limited therapeutic options.

Humane Genomics

This company develops synthetic oncolytic viral therapies to treat cancer patients by engineering viruses that selectively infect and destroy malignant cells.